Table 2 Clinical features of previously reported pleuroperitoneal communication cases successfully treated by pleurodesis with autologous blood
Reference | Age (years) | Sex | Instilled blood volume per time | Number of times | Duration of PD cessation after the last blood instillation | Adverse effects |
|---|---|---|---|---|---|---|
21 | 38 | M | 100 mL | 3 | N.D. | N.D. |
10 | 24 | F | 40 mL | 1 | 21 days | None |
11 | 80 | F | 40 mL | 2 | 4 weeks | None |
22 | 54 | M | 100 mL | 1 | 24 h | None |
23 | 58 | M | 40 mL (first time) 50 mL (second time) | 2 | 8 weeks | None |
Present case | 58 | M | 50 mL | 1 | 5 days | None |